Burns J W & Co. Inc. NY decreased its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 0.8% during the 1st quarter, HoldingsChannel reports. The fund owned 10,226 shares of the company’s stock after selling 83 shares during the quarter. Burns J W & Co. Inc. NY’s holdings in Clorox were worth $1,566,000 at the end of the most recent quarter.
A number of other hedge funds have also recently modified their holdings of the company. Fortitude Family Office LLC purchased a new position in shares of Clorox during the 4th quarter worth $29,000. Northwest Financial Advisors acquired a new position in shares of Clorox in the 4th quarter worth approximately $29,000. Core Wealth Advisors Inc. purchased a new position in shares of Clorox during the 4th quarter worth approximately $29,000. First United Bank & Trust acquired a new stake in Clorox in the 4th quarter valued at approximately $31,000. Finally, GoalVest Advisory LLC purchased a new stake in Clorox in the first quarter valued at approximately $31,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Clorox Stock Down 0.1 %
Shares of NYSE CLX traded down $0.13 during mid-day trading on Friday, reaching $136.47. The company had a trading volume of 1,667,373 shares, compared to its average volume of 1,254,727. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.14. The stock has a market cap of $16.95 billion, a P/E ratio of 70.72, a PEG ratio of 2.19 and a beta of 0.39. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The firm has a 50 day simple moving average of $136.95 and a two-hundred day simple moving average of $143.79.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. dropped their price objective on Clorox from $159.00 to $158.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Morgan Stanley reissued an “equal weight” rating and set a $160.00 price target on shares of Clorox in a research report on Tuesday, March 26th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a report on Wednesday, April 17th. Argus raised shares of Clorox to a “hold” rating in a research report on Tuesday, June 4th. Finally, Jefferies Financial Group raised Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price objective on the stock in a research report on Tuesday, March 26th. Five equities research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $145.33.
Get Our Latest Stock Analysis on CLX
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- Insider Buying Explained: What Investors Need to Know
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- MarketBeat Week in Review – 6/24 – 6/28
- Investing In Automotive Stocks
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.